Finland: Difference between revisions
Tag: Reverted |
|||
| Line 32: | Line 32: | ||
'''Information/Contact for data request:''' [https://stat.fi/en/statistics/documentation/ksyyt#Source%20data%20and%20data%20collections Information on how to access the data can be found here.] | '''Information/Contact for data request:''' [https://stat.fi/en/statistics/documentation/ksyyt#Source%20data%20and%20data%20collections Information on how to access the data can be found here.] | ||
=== THL Biobank === | |||
'''Primary purpose:''' | |||
'''Sponsor, manager or home institution:''' | |||
'''Type of information:''' | |||
'''Source of Information:''' | |||
'''Data level:''' | |||
'''Number of Records:''' | |||
'''Date Range:''' | |||
'''Cancer Areas of Interest:''' | |||
'''Open data access:''' | |||
'''Information/Contact for data request:''' | |||
== [[Clinical Study Databases]] == | == [[Clinical Study Databases]] == | ||
Revision as of 22:04, 5 January 2023
Cancer Centers
Healthcare System
Finland has a universal healthcare system funded by taxes. The Ministry of Social Affairs and Health is responsible for health regulations and assessment countrywide, while municipalities are responsible for providing access to health services at all levels of care. From the public health expenditure, what isn't covered by the national and local taxes is funded by the National Health Insurance.
Administrative or Claims Data
Registries
Statistics Finland - Cause of Death
Primary purpose: Provide publicly available information on causes of death.
Sponsor, manager or home institution: Statistics Finland; Ministry of Finance.
Available type of information: Deaths by underlying cause of death, age, sex, and county.
Source of Information: Death certificates and data from the Population Information System.
Data level: Patient level.
Available data level: Regional level.
Number of Records: Unknown.
Date Range: From 1969 onwards.
Cancer Areas of Interest (ICD-10): Neoplasms (C00-D48); malignant neoplasms (C00-C97); malignant neoplasm of lip, oral cavity and pharynx (C00-C14); malignant neoplasm of oesophagus (C15); malignant neoplasm of stomach (C16); malignant neoplasm of colon (C18, C19); malignant neoplasm of rectum, anus and anal canal (C20-C21); primary malignant neoplasm of liver and intrahepatic bile ducts (C22); malignant neoplasm of pancreas (C25); malignant neoplasm of larynx, trachea, bronchus and lung (C32-C34); malignant melanoma of skin (C43); malignant neoplasm of breast (C50); malignant neoplasm of cervix uteri (C53); malignant neoplasm of uterus (C54-C55); malignant neoplasm of ovary (C56); malignant neoplasm of prostate (C61); malignant neoplasm of kidney (C64); malignant neoplasm of bladder (C67); malignant neoplasm of lymphoid, haematopoietic and related tissue (C81-C96), other malignant neoplasms; other neoplasms (D00-D48)
Open data access: Partially publicly available data. Information can be found here.
Information/Contact for data request: Information on how to access the data can be found here.
THL Biobank
Primary purpose:
Sponsor, manager or home institution:
Type of information:
Source of Information:
Data level:
Number of Records:
Date Range:
Cancer Areas of Interest:
Open data access:
Information/Contact for data request:
Clinical Study Databases
Electronic Health Records
Clinical Practices Guidelines
Latest Policymaking Initiatives
Survey: FinSote - Lifestyle and Risk Factors
Sponsor, manager or home institution: Finnish Institute for Health and Welfare
Primary purpose:' The FinSote National health survey aims to monitor the changes in the population's well-being and health.
Type of information: Proportion of daily smokers, proportion of daily users of e-cigarettes containing nicotine, and Proportion of daily users of tobacco products or e-cigarettes containing nicotine.
'Level: National level.
Access to information: Information can be found here.
